Arquivos de Neuro-Psiquiatria, 2010 In order to evaluate the long-term effect of botulinum toxin type A (BTX) in the treatment of hemifacial spasm (HFS), a retrospective analysis of patients treated at the Movement Disorders Unit of the Division of Neurology, Clinical Hospital, University ...
Egberto Reis Barbosa +5 more
doaj +1 more source
Estrabismo após toxina botulínica para fins estéticos
Revista Brasileira de Oftalmologia, 2011 RESUMO Nas últimas décadas, a toxina botulínica tem sido aplicada para fins terapêuticos em inúmeras afecções. A toxina do tipo A foi aprovada primeiramente em 1989 para o uso em estrabismo, blefaroespasmo e espasmo hemifacial de pacientes maiores que 12
Marta Halfeld Ferrari Alves Lacordia +2 more
doaj +1 more source
Botulinum toxin use in neurology: Experience at Guillermo Almenara Irigoyen EsSalud Hospital [PDF]
, 2004 Objetivo: Identificar las principales utilidades de la toxina botulínica en las enfermedades neurológicas. Lugar: Hospital Nacional Guillermo Almenara Irigoyen, EsSalud, Lima,Perú. Periodo 2001-2003. Material y Métodos: Se estudió 122 pacientes a quienes
CASTAÑEDA, CÉSAR +3 more
core +3 more sources
Toxina botulínica para uso terapéutico [PDF]
, 2006 From the year 1980 the intramuscular inoculation of botulinal neurotoxin (BoNT) is realized for treatment of disorders of the muscular tone. The simplicity of the treatment does an excellent alternative to the surgery.
Fernandez, Rafael Alfredo +5 more
core
Influência da toxina botulínica tipo A na função lacrimal de pacientes com distonias faciais [PDF]
, 2010 OBJETIVO: Avaliar a influência da toxina botulínica na função lacrimal de pacientes com distonias faciais. MÉTODOS: Pacientes com diagnóstico de espasmo hemifacial ou blefaroespasmo essencial em atividade foram clinicamente avaliados e responderam ...
Angelino Julio Cariello +4 more
core +2 more sources
Blepharospasm and hemifacial spasm: Long-term treatment with botulinum toxin
Neurología (English Edition), 2013 Introduction: Our purpose is to describe the demographic, clinical and therapeutic characteristics of patients with blepharospasm (BS) and hemifacial spasm (HFS) during treatment with botulinum toxin type A (BtA).
C. Gil Polo +7 more
doaj +1 more source
Peripheral Facial Paralysis: the Role of Physical Medicine and Rehabilitation [PDF]
, 2011 A paralisia facial periférica (PFP) resulta da lesão neuronal periférica do nervo facial (NF). Pode ser primária (Paralisia de Bell) ou secundária.
Matos, C
core
Hemimasticatory Spasm: Report of a Case and Review of the Literature [PDF]
, 2014 Background: Hemimasticatory Spasm is a very rare disorder. Case report: A 62-year-old woman consulted with 30 years of unusual involuntary twitches in preauricular region and spasms that hamper jaw opening.
Arakaki, Tomoko +4 more
core +2 more sources
Arquivos de Neuro-Psiquiatria, 2009 BACKGROUND: Non-motor symptoms have been described in primary dystonia, but the results on cognitive impairment in this condition are discordant. Blepharospasm (BM) is a type of primary focal dystonia characterized by recurrent and involuntary eye ...
Fernando Machado Vilhena Dias +5 more
doaj +1 more source
Uso de agente paralisante da função neuromuscular aplicado no tratamento de comorbidades relacionadas à região de cabeça e pescoço de pacientes atendidos do Humap-UFMS/EBSERH, a partir do emprego da Toxina Botulínica Tipo A (TBA) [PDF]
, 2022 Demand submitted by the Head and Neck Unit UCA/DGC/GAS/Humap-UFMS to the Center for Health Technology Assessment (NATS) at the Maria Aparecida Pedrossian University Hospital HumapUFMS/Ebserh for the use of a neuromuscular function paralyzing agent ...
Ulisses, Masseli Dias
core